SEC Form 4 research
| Issuer | AdvanSource Biomaterials Corp |
|---|---|
| Tickers | CTE, ASB, ASNB, NORD |
| Reporting owners | 21 |
| Officers and directors | 4 |
| Last public filing | 2026-11-12 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-11-12 | 2026-07-08 | AC Nordic ApS | P | 20,000 | $2 | Not reported |
| 2026-11-10 | 2026-11-05 | Yankowitz Bennett J. | A | 1,000,000 | $0 | Not reported |
| 2026-11-10 | 2026-11-05 | Rouf Henrik | A | 2,000,000 | $0 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.